drugset / Trial / NCT00236717

A Study of the Effectiveness and Safety of Topiramate Compared With a Standard Therapy in Patients Newly Diagnosed With Epilepsy

NCT00236717

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to compare the effectiveness and safety of topiramate to standard antiepileptic drugs in children and adults with newly diagnosed epilepsy.

Timeline

Start
1997-09
Primary completion
Completion
2000-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Carbamazepine Small molecule 600 mg
Subject Topiramate Small molecule 100 mg Oral
Subject Topiramate Small molecule 200 mg Oral
Subject Valproate Small molecule 1250 mg

Indications